Emergent BioSolutions Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.98 | -$0.98 | -$0.98 |
| Q2 2024 | 1 | -$1.14 | -$1.14 | -$1.14 |
| Q3 2024 | 1 | $0.10 | $0.10 | $0.10 |
| Q4 2024 | 1 | -$0.15 | -$0.15 | -$0.15 |
| Q1 2025 | 1 | $1.50 | $1.50 | $1.50 |
| Q2 2025 | 1 | $0.14 | $0.14 | $0.14 |
| Q3 2025 | 1 | $1.29 | $1.29 | $1.29 |
| Q4 2025 | 1 | $0.04 | $0.04 | $0.04 |
Emergent BioSolutions Inc. Earnings Date And Information
Emergent BioSolutions Inc. last posted its earnings results on Tuesday, August 6th, 2024. The company reported $-2.32 earnings per share for the quarter, missing analysts' consensus estimates of $-0.97 by $1.35. The company had revenue of 254.70 M for the quarter and had revenue of 1.05 B for the year. Emergent BioSolutions Inc. has generated $-15 earnings per share over the last year ($-14.85 diluted earnings per share) and currently has a price-to-earnings ratio of -0.98. Emergent BioSolutions Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based on prior year's report dates.
Emergent BioSolutions Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/06/2024 | Q2 2024 | -$5.38 | $190.00 M | $254.70 M | ||
| 03/30/2024 | Q1 2024 | $0.17 | $300.40 M | |||
| 03/08/2024 | Q4 2023 | -$0.95 | $276.60 M | |||
| 12/11/2023 | Q3 2023 | -$0.22 | -$5.13 | -4.91 | $237.43 M | $270.50 M |
| 08/08/2023 | Q2 2023 | -$5.15 | $216.17 M | $337.90 M | ||
| 05/09/2023 | Q1 2023 | -$3.65 | $165.10 M | |||
| 12/11/2023 | Q4 2022 | -$0.22 | -$1.76 | -1.54 | $330.70 M | |
| 11/08/2022 | Q3 2022 | -$1.52 | $268.30 M | $240.00 M | ||
| 08/01/2022 | Q2 2022 | -$1.13 | $270.94 M | $242.70 M | ||
| 04/28/2022 | Q1 2022 | -$0.07 | $307.50 M | |||
| 02/25/2022 | Q4 2021 | $3.54 | $723.20 M | |||
| 11/05/2021 | Q3 2021 | -$0.61 | $486.84 M | $329.00 M | ||
| 07/29/2021 | Q2 2021 | $0.09 | $398.93 M | $397.50 M | ||
| 04/29/2021 | Q1 2021 | $1.31 | $343.00 M | |||
| 02/18/2021 | Q4 2020 | $3.51 | $583.00 M | |||
| 11/05/2020 | Q3 2020 | $0.75 | $437.89 M | $385.20 M | ||
| 07/31/2020 | Q2 2020 | $1.76 | $294.72 M | $394.70 M | ||
| 04/30/2020 | Q1 2020 | -$0.24 | $192.50 M | |||
| 02/24/2020 | Q4 2019 | $0.91 | $360.40 M | |||
| 11/06/2019 | Q3 2019 | $0.84 | $289.27 M | $311.80 M |
Emergent BioSolutions Inc. Earnings: Frequently Asked Questions
-
When is Emergent BioSolutions Inc.'s earnings date?
Emergent BioSolutions Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based off last year's report dates.
-
How can I listen to Emergent BioSolutions Inc.'s earnings conference call?
The conference call for Emergent BioSolutions Inc.'s latest earnings report can be listened to online.
-
How can I read Emergent BioSolutions Inc.'s conference call transcript?
The conference call transcript for Emergent BioSolutions Inc.'s latest earnings report can be read online.
-
How much revenue does Emergent BioSolutions Inc. generate each year?
Emergent BioSolutions Inc. (:EBS) has a recorded annual revenue of $1.05 B.
-
How much profit does Emergent BioSolutions Inc. generate each year?
Emergent BioSolutions Inc. (:EBS) has a recorded net income of $1.05 B. Emergent BioSolutions Inc. has generated $-14.85 earnings per share over the last four quarters.
-
What is Emergent BioSolutions Inc.'s price-to-earnings ratio?
Emergent BioSolutions Inc. (:EBS) has a price-to-earnings ratio of -0.98 and price/earnings-to-growth ratio is 0.47.
